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This thesis is a result of intention to prepare potential effective derivatives from 
pyrazinamide (PZA) structure. These results contribute to enrichment of the research of new 
antituberculars (antiTBC) which has been carried out at the Dpt. of Pharmaceutical Chemistry 
and Drug Control at the Faculty of Pharmacy in Hradec Králové. 
The aim of the research to produce the new effective antituberculars is supported by the 
contemporary state of tuberculosis in the world. This state is closely described in this thesis. 
Despite of decreasing number of new cases in all six WHO regions, spreading of this infectious 
disease is not under the control. The main reason is a resistance formation of new mycobacterial 
strains which can cause hardly treatable cases. The prepared substances are PZA derivatives 
which represent one of the most important first line drugs for tuberculosis treatment. The latest 
research focused on mechanism of PZA showed new information which was included in this 
thesis.  
Furthermore, some new systems for delivery of antiTBCs are presented here. They 
involve inhalation systems and just this administration of drugs can make treatment of this 
disease more effective. It includes inhalation systems, an effective way of drug administration. 
Promising results were shown during the testing on animals. 
As a part of this thesis, 12 new PZA derivatives were prepared. It includes a series of 
5-(alkylamino)-N-phenylpyrazine-2-carboxamides and 5-(alkylamino)-N-
(2-chlorophenyl)pyrazine-2-carboxamides. The prepared compounds were characterized by 




C NMR and infrared spectra. The compounds were 
evaluated for antimycobacterial activity (Mycobacterium tuberculosis, M. kansasii a two stems 
of M. avium), and in addition also for activity against selected bacterial and fungal pathogens.  
5-(Alkylamino)-N-phenylpyrazine-2-carboxamides  inhibited  the growth of M. tuberculosis at 
concentrations of 0,78 – 3,13 µg.mL
-1
, which was superior to PZA standard.  
 
 
     
